COVID-19 Impact on Global Human Recombinant Insulin Market Insights, Forecast to 2026

COVID-19 Impact on Global Human Recombinant Insulin Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Human Recombinant Insulin Product Introduction
1.2 Market Segments
1.3 Key Human Recombinant Insulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Recombinant Insulin Market Size Growth Rate by Type
1.4.2 Rapid-Acting Human Insulin
1.4.3 Regular (Short Acting) Insulin
1.4.4 NPH (Intermediate Acting) Insulin
1.4.5 Long-Acting Human Insulin
1.4.6 Premixed Human Insulins Insulin
1.5 Market by Application
1.5.1 Global Human Recombinant Insulin Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacies
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Human Recombinant Insulin Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Recombinant Insulin Industry
1.6.1.1 Human Recombinant Insulin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Recombinant Insulin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Recombinant Insulin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Human Recombinant Insulin Market Size Estimates and Forecasts
2.1.1 Global Human Recombinant Insulin Revenue 2015-2026
2.1.2 Global Human Recombinant Insulin Sales 2015-2026
2.2 Human Recombinant Insulin Market Size by Region: 2020 Versus 2026
2.2.1 Global Human Recombinant Insulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Recombinant Insulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Recombinant Insulin Competitor Landscape by Players
3.1 Human Recombinant Insulin Sales by Manufacturers
3.1.1 Human Recombinant Insulin Sales by Manufacturers (2015-2020)
3.1.2 Human Recombinant Insulin Sales Market Share by Manufacturers (2015-2020)
3.2 Human Recombinant Insulin Revenue by Manufacturers
3.2.1 Human Recombinant Insulin Revenue by Manufacturers (2015-2020)
3.2.2 Human Recombinant Insulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Recombinant Insulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Recombinant Insulin Revenue in 2019
3.2.5 Global Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Recombinant Insulin Price by Manufacturers
3.4 Human Recombinant Insulin Manufacturing Base Distribution, Product Types
3.4.1 Human Recombinant Insulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Recombinant Insulin Product Type
3.4.3 Date of International Manufacturers Enter into Human Recombinant Insulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Human Recombinant Insulin Market Size by Type (2015-2020)
4.1.1 Global Human Recombinant Insulin Sales by Type (2015-2020)
4.1.2 Global Human Recombinant Insulin Revenue by Type (2015-2020)
4.1.3 Human Recombinant Insulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Recombinant Insulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Recombinant Insulin Sales Forecast by Type (2021-2026)
4.2.2 Global Human Recombinant Insulin Revenue Forecast by Type (2021-2026)
4.2.3 Human Recombinant Insulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Recombinant Insulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Human Recombinant Insulin Market Size by Application (2015-2020)
5.1.1 Global Human Recombinant Insulin Sales by Application (2015-2020)
5.1.2 Global Human Recombinant Insulin Revenue by Application (2015-2020)
5.1.3 Human Recombinant Insulin Price by Application (2015-2020)
5.2 Human Recombinant Insulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Recombinant Insulin Sales Forecast by Application (2021-2026)
5.2.2 Global Human Recombinant Insulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Recombinant Insulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Recombinant Insulin by Country
6.1.1 North America Human Recombinant Insulin Sales by Country
6.1.2 North America Human Recombinant Insulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Recombinant Insulin Market Facts & Figures by Type
6.3 North America Human Recombinant Insulin Market Facts & Figures by Application
7 Europe
7.1 Europe Human Recombinant Insulin by Country
7.1.1 Europe Human Recombinant Insulin Sales by Country
7.1.2 Europe Human Recombinant Insulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Recombinant Insulin Market Facts & Figures by Type
7.3 Europe Human Recombinant Insulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Recombinant Insulin by Region
8.1.1 Asia Pacific Human Recombinant Insulin Sales by Region
8.1.2 Asia Pacific Human Recombinant Insulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Recombinant Insulin Market Facts & Figures by Type
8.3 Asia Pacific Human Recombinant Insulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Recombinant Insulin by Country
9.1.1 Latin America Human Recombinant Insulin Sales by Country
9.1.2 Latin America Human Recombinant Insulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Recombinant Insulin Market Facts & Figures by Type
9.3 Central & South America Human Recombinant Insulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Recombinant Insulin by Country
10.1.1 Middle East and Africa Human Recombinant Insulin Sales by Country
10.1.2 Middle East and Africa Human Recombinant Insulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Recombinant Insulin Market Facts & Figures by Type
10.3 Middle East and Africa Human Recombinant Insulin Market Facts & Figures by Application
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Human Recombinant Insulin Products Offered
11.1.5 Novo Nordisk Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Description, Business Overview and Total Revenue
11.2.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly and Company Human Recombinant Insulin Products Offered
11.2.5 Eli Lilly and Company Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Human Recombinant Insulin Products Offered
11.3.5 Sanofi Recent Development
11.4 Julphar Gulf Pharmaceutical Industries
11.4.1 Julphar Gulf Pharmaceutical Industries Corporation Information
11.4.2 Julphar Gulf Pharmaceutical Industries Description, Business Overview and Total Revenue
11.4.3 Julphar Gulf Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Products Offered
11.4.5 Julphar Gulf Pharmaceutical Industries Recent Development
11.5 Bioton
11.5.1 Bioton Corporation Information
11.5.2 Bioton Description, Business Overview and Total Revenue
11.5.3 Bioton Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bioton Human Recombinant Insulin Products Offered
11.5.5 Bioton Recent Development
11.6 Gan & Lee Pharmaceuticals
11.6.1 Gan & Lee Pharmaceuticals Corporation Information
11.6.2 Gan & Lee Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Gan & Lee Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Products Offered
11.6.5 Gan & Lee Pharmaceuticals Recent Development
11.7 Zhuhai United Laboratories
11.7.1 Zhuhai United Laboratories Corporation Information
11.7.2 Zhuhai United Laboratories Description, Business Overview and Total Revenue
11.7.3 Zhuhai United Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Zhuhai United Laboratories Human Recombinant Insulin Products Offered
11.7.5 Zhuhai United Laboratories Recent Development
11.8 Biocon
11.8.1 Biocon Corporation Information
11.8.2 Biocon Description, Business Overview and Total Revenue
11.8.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biocon Human Recombinant Insulin Products Offered
11.8.5 Biocon Recent Development
11.9 Wanbang Biopharmaceuticals
11.9.1 Wanbang Biopharmaceuticals Corporation Information
11.9.2 Wanbang Biopharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Wanbang Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Products Offered
11.9.5 Wanbang Biopharmaceuticals Recent Development
11.10 Dongbao Enterprise Group
11.10.1 Dongbao Enterprise Group Corporation Information
11.10.2 Dongbao Enterprise Group Description, Business Overview and Total Revenue
11.10.3 Dongbao Enterprise Group Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Dongbao Enterprise Group Human Recombinant Insulin Products Offered
11.10.5 Dongbao Enterprise Group Recent Development
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Human Recombinant Insulin Products Offered
11.1.5 Novo Nordisk Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Recombinant Insulin Market Estimates and Projections by Region
12.1.1 Global Human Recombinant Insulin Sales Forecast by Regions 2021-2026
12.1.2 Global Human Recombinant Insulin Revenue Forecast by Regions 2021-2026
12.2 North America Human Recombinant Insulin Market Size Forecast (2021-2026)
12.2.1 North America: Human Recombinant Insulin Sales Forecast (2021-2026)
12.2.2 North America: Human Recombinant Insulin Revenue Forecast (2021-2026)
12.2.3 North America: Human Recombinant Insulin Market Size Forecast by Country (2021-2026)
12.3 Europe Human Recombinant Insulin Market Size Forecast (2021-2026)
12.3.1 Europe: Human Recombinant Insulin Sales Forecast (2021-2026)
12.3.2 Europe: Human Recombinant Insulin Revenue Forecast (2021-2026)
12.3.3 Europe: Human Recombinant Insulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Recombinant Insulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Recombinant Insulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Recombinant Insulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Recombinant Insulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Recombinant Insulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Recombinant Insulin Sales Forecast (2021-2026)
12.5.2 Latin America: Human Recombinant Insulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Recombinant Insulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Recombinant Insulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Recombinant Insulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Recombinant Insulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Recombinant Insulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Recombinant Insulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Recombinant Insulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Human Recombinant Insulin Market Segments
Table 2. Ranking of Global Top Human Recombinant Insulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Recombinant Insulin Market Size Growth Rate by Type 2020-2026 (K Litre) & (US$ Million)
Table 4. Major Manufacturers of Rapid-Acting Human Insulin
Table 5. Major Manufacturers of Regular (Short Acting) Insulin
Table 6. Major Manufacturers of NPH (Intermediate Acting) Insulin
Table 7. Major Manufacturers of Long-Acting Human Insulin
Table 8. Major Manufacturers of Premixed Human Insulins Insulin
Table 9. COVID-19 Impact Global Market: (Four Human Recombinant Insulin Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Human Recombinant Insulin Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Human Recombinant Insulin Players to Combat Covid-19 Impact
Table 14. Global Human Recombinant Insulin Market Size Growth Rate by Application 2020-2026 (K Litre)
Table 15. Global Human Recombinant Insulin Market Size by Region (K Litre) & (US$ Million): 2020 VS 2026
Table 16. Global Human Recombinant Insulin Sales by Regions 2015-2020 (K Litre)
Table 17. Global Human Recombinant Insulin Sales Market Share by Regions (2015-2020)
Table 18. Global Human Recombinant Insulin Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Human Recombinant Insulin Sales by Manufacturers (2015-2020) (K Litre)
Table 20. Global Human Recombinant Insulin Sales Share by Manufacturers (2015-2020)
Table 21. Global Human Recombinant Insulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Human Recombinant Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Recombinant Insulin as of 2019)
Table 23. Human Recombinant Insulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Human Recombinant Insulin Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Human Recombinant Insulin Price (2015-2020) (USD/Litre)
Table 26. Human Recombinant Insulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Human Recombinant Insulin Product Type
Table 28. Date of International Manufacturers Enter into Human Recombinant Insulin Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Human Recombinant Insulin Sales by Type (2015-2020) (K Litre)
Table 31. Global Human Recombinant Insulin Sales Share by Type (2015-2020)
Table 32. Global Human Recombinant Insulin Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Human Recombinant Insulin Revenue Share by Type (2015-2020)
Table 34. Human Recombinant Insulin Average Selling Price (ASP) by Type 2015-2020 (USD/Litre)
Table 35. Global Human Recombinant Insulin Sales by Application (2015-2020) (K Litre)
Table 36. Global Human Recombinant Insulin Sales Share by Application (2015-2020)
Table 37. North America Human Recombinant Insulin Sales by Country (2015-2020) (K Litre)
Table 38. North America Human Recombinant Insulin Sales Market Share by Country (2015-2020)
Table 39. North America Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Human Recombinant Insulin Revenue Market Share by Country (2015-2020)
Table 41. North America Human Recombinant Insulin Sales by Type (2015-2020) (K Litre)
Table 42. North America Human Recombinant Insulin Sales Market Share by Type (2015-2020)
Table 43. North America Human Recombinant Insulin Sales by Application (2015-2020) (K Litre)
Table 44. North America Human Recombinant Insulin Sales Market Share by Application (2015-2020)
Table 45. Europe Human Recombinant Insulin Sales by Country (2015-2020) (K Litre)
Table 46. Europe Human Recombinant Insulin Sales Market Share by Country (2015-2020)
Table 47. Europe Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Human Recombinant Insulin Revenue Market Share by Country (2015-2020)
Table 49. Europe Human Recombinant Insulin Sales by Type (2015-2020) (K Litre)
Table 50. Europe Human Recombinant Insulin Sales Market Share by Type (2015-2020)
Table 51. Europe Human Recombinant Insulin Sales by Application (2015-2020) (K Litre)
Table 52. Europe Human Recombinant Insulin Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Human Recombinant Insulin Sales by Region (2015-2020) (K Litre)
Table 54. Asia Pacific Human Recombinant Insulin Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Human Recombinant Insulin Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Human Recombinant Insulin Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Human Recombinant Insulin Sales by Type (2015-2020) (K Litre)
Table 58. Asia Pacific Human Recombinant Insulin Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Human Recombinant Insulin Sales by Application (2015-2020) (K Litre)
Table 60. Asia Pacific Human Recombinant Insulin Sales Market Share by Application (2015-2020)
Table 61. Latin America Human Recombinant Insulin Sales by Country (2015-2020) (K Litre)
Table 62. Latin America Human Recombinant Insulin Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Human Recombinant Insulin Revenue Market Share by Country (2015-2020)
Table 65. Latin America Human Recombinant Insulin Sales by Type (2015-2020) (K Litre)
Table 66. Latin America Human Recombinant Insulin Sales Market Share by Type (2015-2020)
Table 67. Latin America Human Recombinant Insulin Sales by Application (2015-2020) (K Litre)
Table 68. Latin America Human Recombinant Insulin Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Human Recombinant Insulin Sales by Country (2015-2020) (K Litre)
Table 70. Middle East and Africa Human Recombinant Insulin Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Human Recombinant Insulin Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Human Recombinant Insulin Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Human Recombinant Insulin Sales by Type (2015-2020) (K Litre)
Table 74. Middle East and Africa Human Recombinant Insulin Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Human Recombinant Insulin Sales by Application (2015-2020) (K Litre)
Table 76. Middle East and Africa Human Recombinant Insulin Sales Market Share by Application (2015-2020)
Table 77. Novo Nordisk Corporation Information
Table 78. Novo Nordisk Description and Major Businesses
Table 79. Novo Nordisk Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 80. Novo Nordisk Product
Table 81. Novo Nordisk Recent Development
Table 82. Eli Lilly and Company Corporation Information
Table 83. Eli Lilly and Company Description and Major Businesses
Table 84. Eli Lilly and Company Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 85. Eli Lilly and Company Product
Table 86. Eli Lilly and Company Recent Development
Table 87. Sanofi Corporation Information
Table 88. Sanofi Description and Major Businesses
Table 89. Sanofi Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 90. Sanofi Product
Table 91. Sanofi Recent Development
Table 92. Julphar Gulf Pharmaceutical Industries Corporation Information
Table 93. Julphar Gulf Pharmaceutical Industries Description and Major Businesses
Table 94. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 95. Julphar Gulf Pharmaceutical Industries Product
Table 96. Julphar Gulf Pharmaceutical Industries Recent Development
Table 97. Bioton Corporation Information
Table 98. Bioton Description and Major Businesses
Table 99. Bioton Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 100. Bioton Product
Table 101. Bioton Recent Development
Table 102. Gan & Lee Pharmaceuticals Corporation Information
Table 103. Gan & Lee Pharmaceuticals Description and Major Businesses
Table 104. Gan & Lee Pharmaceuticals Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 105. Gan & Lee Pharmaceuticals Product
Table 106. Gan & Lee Pharmaceuticals Recent Development
Table 107. Zhuhai United Laboratories Corporation Information
Table 108. Zhuhai United Laboratories Description and Major Businesses
Table 109. Zhuhai United Laboratories Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 110. Zhuhai United Laboratories Product
Table 111. Zhuhai United Laboratories Recent Development
Table 112. Biocon Corporation Information
Table 113. Biocon Description and Major Businesses
Table 114. Biocon Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 115. Biocon Product
Table 116. Biocon Recent Development
Table 117. Wanbang Biopharmaceuticals Corporation Information
Table 118. Wanbang Biopharmaceuticals Description and Major Businesses
Table 119. Wanbang Biopharmaceuticals Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 120. Wanbang Biopharmaceuticals Product
Table 121. Wanbang Biopharmaceuticals Recent Development
Table 122. Dongbao Enterprise Group Corporation Information
Table 123. Dongbao Enterprise Group Description and Major Businesses
Table 124. Dongbao Enterprise Group Human Recombinant Insulin Production (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 125. Dongbao Enterprise Group Product
Table 126. Dongbao Enterprise Group Recent Development
Table 127. PeproTech Corporation Information
Table 128. PeproTech Description and Major Businesses
Table 129. PeproTech Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Price (USD/Litre) and Gross Margin (2015-2020)
Table 130. PeproTech Product
Table 131. PeproTech Recent Development
Table 132. Global Human Recombinant Insulin Sales Forecast by Regions (2021-2026) (K Litre)
Table 133. Global Human Recombinant Insulin Sales Market Share Forecast by Regions (2021-2026)
Table 134. Global Human Recombinant Insulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 135. Global Human Recombinant Insulin Revenue Market Share Forecast by Regions (2021-2026)
Table 136. North America: Human Recombinant Insulin Sales Forecast by Country (2021-2026) (K Litre)
Table 137. North America: Human Recombinant Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Europe: Human Recombinant Insulin Sales Forecast by Country (2021-2026) (K Litre)
Table 139. Europe: Human Recombinant Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Asia Pacific: Human Recombinant Insulin Sales Forecast by Region (2021-2026) (K Litre)
Table 141. Asia Pacific: Human Recombinant Insulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 142. Latin America: Human Recombinant Insulin Sales Forecast by Country (2021-2026) (K Litre)
Table 143. Latin America: Human Recombinant Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Middle East and Africa: Human Recombinant Insulin Sales Forecast by Country (2021-2026) (K Litre)
Table 145. Middle East and Africa: Human Recombinant Insulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Human Recombinant Insulin Players
Table 150. Human Recombinant Insulin Customers List
Table 151. Human Recombinant Insulin Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Recombinant Insulin Product Picture
Figure 2. Global Human Recombinant Insulin Sales Market Share by Type in 2020 & 2026
Figure 3. Rapid-Acting Human Insulin Product Picture
Figure 4. Regular (Short Acting) Insulin Product Picture
Figure 5. NPH (Intermediate Acting) Insulin Product Picture
Figure 6. Long-Acting Human Insulin Product Picture
Figure 7. Premixed Human Insulins Insulin Product Picture
Figure 8. Global Human Recombinant Insulin Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Online Pharmacies
Figure 12. Other
Figure 13. Human Recombinant Insulin Report Years Considered
Figure 14. Global Human Recombinant Insulin Market Size 2015-2026 (US$ Million)
Figure 15. Global Human Recombinant Insulin Sales 2015-2026 (K Litre)
Figure 16. Global Human Recombinant Insulin Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Human Recombinant Insulin Sales Market Share by Region (2015-2020)
Figure 18. Global Human Recombinant Insulin Sales Market Share by Region in 2019
Figure 19. Global Human Recombinant Insulin Revenue Market Share by Region (2015-2020)
Figure 20. Global Human Recombinant Insulin Revenue Market Share by Region in 2019
Figure 21. Global Human Recombinant Insulin Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Human Recombinant Insulin Revenue in 2019
Figure 23. Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Human Recombinant Insulin Sales Market Share by Type (2015-2020)
Figure 25. Global Human Recombinant Insulin Sales Market Share by Type in 2019
Figure 26. Global Human Recombinant Insulin Revenue Market Share by Type (2015-2020)
Figure 27. Global Human Recombinant Insulin Revenue Market Share by Type in 2019
Figure 28. Global Human Recombinant Insulin Market Share by Price Range (2015-2020)
Figure 29. Global Human Recombinant Insulin Sales Market Share by Application (2015-2020)
Figure 30. Global Human Recombinant Insulin Sales Market Share by Application in 2019
Figure 31. Global Human Recombinant Insulin Revenue Market Share by Application (2015-2020)
Figure 32. Global Human Recombinant Insulin Revenue Market Share by Application in 2019
Figure 33. North America Human Recombinant Insulin Sales Growth Rate 2015-2020 (K Litre)
Figure 34. North America Human Recombinant Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Human Recombinant Insulin Sales Market Share by Country in 2019
Figure 36. North America Human Recombinant Insulin Revenue Market Share by Country in 2019
Figure 37. U.S. Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 38. U.S. Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 40. Canada Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Human Recombinant Insulin Market Share by Type in 2019
Figure 42. North America Human Recombinant Insulin Market Share by Application in 2019
Figure 43. Europe Human Recombinant Insulin Sales Growth Rate 2015-2020 (K Litre)
Figure 44. Europe Human Recombinant Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Human Recombinant Insulin Sales Market Share by Country in 2019
Figure 46. Europe Human Recombinant Insulin Revenue Market Share by Country in 2019
Figure 47. Germany Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 48. Germany Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 50. France Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 52. U.K. Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 54. Italy Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 56. Russia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Human Recombinant Insulin Market Share by Type in 2019
Figure 58. Europe Human Recombinant Insulin Market Share by Application in 2019
Figure 59. Asia Pacific Human Recombinant Insulin Sales Growth Rate 2015-2020 (K Litre)
Figure 60. Asia Pacific Human Recombinant Insulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Human Recombinant Insulin Sales Market Share by Region in 2019
Figure 62. Asia Pacific Human Recombinant Insulin Revenue Market Share by Region in 2019
Figure 63. China Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 64. China Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 66. Japan Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 68. South Korea Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 70. India Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 72. Australia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 74. Taiwan Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 76. Indonesia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 78. Thailand Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 80. Malaysia Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 82. Philippines Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Human Recombinant Insulin Sales Growth Rate (2015-2020) (K Litre)
Figure 84. Vietnam Human Recombinant Insulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Human Recombinant Insulin Market Share by Type in 2019
Figure 86. Asia Pacific Human Recombinant Insulin Market Share by Application in 2019
Figure 87. Latin America Human Recombinant Insulin Sales Growth Rate 2015-2020 (K Litre)
Figure 88. Lati

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs